Martin Madaus

Martin Madaus

Ordförande på REPLIGEN CORPORATION

Förmögenhet: 2 M $ per 2026-05-31

66 år
Health Technology
Commercial Services
Health Services

Profil

Dr. Martin D.
Madaus
is an Independent Director at Azenta, Inc., a Chairman at Repligen Corp.
and an Executive Chairman at Emulate, Inc. He is on the Board of Directors at Azenta, Inc., Unchained Labs LLC, Candela Medical, Inc., Candela Corp., Massachusetts High Technology Council, Inc., Syntis Bio, Inc. and Ultivue, Inc. Dr. Madaus was previously employed as an Independent Director by Hologic, Inc., an Independent Director by Standard BioTools, Inc., a Chief Operations Officer by Sherlock Biosciences, Inc., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, Inc., an Independent Director by Covidien Ltd., an Independent Director by Mettler-Toledo International, Inc., a Chairman, President & Chief Executive Officer by Millipore Corp., a Chairman, President & Chief Executive Officer by Millipore SA/NV, a President & Chief Executive Officer by Roche Diagnostics Corp., a Chairman & Chief Executive Officer by Ortho-Clinical Diagnostics, and a Vice President-Business Development by Roche Molecular Systems, Inc. He also served on the board at Quanterix Corp., Analytical Life Science & Diagnostics Association, Massachusetts Technology Collaborative, New England Healthcare Institute, Pharmaceutical Product Development LLC, Predictive Biosciences, Inc. and Young Men's Christian Association of Greater Boston, Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München and a doctorate degree from The University of Veterinary Medicine Hanover.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-05-14 8 392 ( 0,01 % ) 1 M $ 2026-05-31
2025-01-02 291 541 ( 0,63 % ) 892 115 $ 2026-05-31
2026-02-05 7 405 ( 0,02 % ) 169 426 $ 2026-05-31

Aktiva positioner av Martin Madaus

FöretagPositionStart
CANDELA MEDICAL, INC. Direktör/Styrelseledamot 2018-05-01
REPLIGEN CORPORATION Ordförande 2026-03-13
AZENTA, INC. Direktör/Styrelseledamot 2024-01-30
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot 2021-07-01
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Ordförande 2020-03-19

Tidigare kända positioner av Martin Madaus

FöretagPositionSlut
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Martin Madauss erfarenhet

Martin Madauss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

68

Första gradens relationer

29

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag29

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Martin Madaus
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU